Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM) announced its participation in the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 3:45 p.m. ET. The event will be available via live webcast on the company's website, with an archived version accessible for 30 days post-event. Insmed is focused on transforming the lives of patients with serious and rare diseases, notably with its first commercial product targeting a chronic lung disease and an expanding pipeline for unmet needs.

BRIDGEWATER, N.J., Jan. 4, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual 40^th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:45 p.m. ET.

The presentation and question and answer session will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301449964.html

SOURCE Insmed Incorporated

FAQ

When is Insmed presenting at the J.P. Morgan Healthcare Conference?

Insmed will present on January 10, 2022, at 3:45 p.m. ET.

Where can I watch Insmed's presentation at the conference?

The presentation will be webcast live on Insmed's investor relations page.

What is Insmed's mission?

Insmed aims to transform the lives of patients with serious and rare diseases.

What is Insmed's first commercial product?

Insmed's first commercial product is a therapy approved for a chronic, debilitating lung disease.

What type of diseases is Insmed targeting in its pipeline?

Insmed's pipeline focuses on neutrophil-mediated inflammatory diseases and rare pulmonary disorders.